©The Author(s) 2015.
World J Gastroenterol. Feb 7, 2015; 21(5): 1580-1587
Published online Feb 7, 2015. doi: 10.3748/wjg.v21.i5.1580
Published online Feb 7, 2015. doi: 10.3748/wjg.v21.i5.1580
Table 1 Baseline characteristics
| Stent type | P value | ||
| Uncovered(n = 38) | Covered(n = 29) | ||
| Age (yr) | 68.9 ± 10.2 | 68.5 ± 11.2 | 0.860 |
| Sex (M/F) | 18/20 (47.4/52.6) | 11/18 (37.9/62.1) | 0.440 |
| ECOG PS (0/1/2/3/4) | 0/9/16/9/4 | 0/5/10/8/6 | 0.2031 |
| Previous treatment | |||
| Operation | 6 (9.0) | 5 (7.5) | 1.000 |
| Chemotherapy | 10 (14.9) | 5 (7.5) | 0.377 |
| Previous biliary drainage | |||
| PTBD | 5 (13.2) | 7 (24.1) | 0.246 |
| ERBD | 19 (50.0) | 8 (27.6) | 0.064 |
| PTBD and ERBD | 5 (13.2) | 0 (0.0) | 0.064 |
| Underlying malignancy | 0.4231 | ||
| Pancreatic cancer | 22 (32.8) | 9 (13.4) | |
| Bile duct cancer | 4 (6.0) | 8 (11.9) | |
| Gallbladder cancer | 4 (6.0) | 5 (7.5) | |
| Ampullary cancer | 3 (4.5) | 2 (3.0) | |
| Duodenal cancer | 1 (1.5) | 3 (4.5) | |
| Hepatocellular carcinoma | 1 (1.5) | 1 (1.5) | |
| Others | 3 (4.5) | 1 (1.5) | |
| Cancer stage | 0.3351 | ||
| I | 1 (2.6) | 1 (3.4) | |
| II | 3 (7.9) | 5 (17.2) | |
| III | 2 (5.3) | 1 (3.4) | |
| IV | 32 (84.2) | 22 (75.9) | |
| Stent diameter (mm) | 19.8 ± 0.55 | 19.4 ± 0.92 | 0.699 |
| Stent length (mm) | 99.5 ± 17.1 | 101.4 ± 14.3 | 0.688 |
| Stent number | 0.256 | ||
| 1 stent | 35 (53.0) | 28 (42.4) | |
| 2 stents | 3 (4.5) | 0 (0.0) | |
| Median time interval to intervention from | 96.5 (3-803) | 118.0 (1-2930) | 0.699 |
| Initial diagnosis (d) | |||
| Chemotherapy after procedure | 11 (28.9) | 5 (17.2) | 0.265 |
| Median duration of follow-up (d) | 71 (8-592) | 60 (9-827) | 0.411 |
- Citation: Kim JW, Jeong JB, Lee KL, Kim BG, Ahn DW, Lee JK, Kim SH. Comparison between uncovered and covered self-expandable metal stent placement in malignant duodenal obstruction. World J Gastroenterol 2015; 21(5): 1580-1587
- URL: https://www.wjgnet.com/1007-9327/full/v21/i5/1580.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i5.1580